Determines the minimally clinically important difference in autoimmune encephalitis, suggesting a new benchmark for clinical response.
We aim to determine the minimally clinically important difference (MCID) of the Clinical Assessment Scale in Autoimmune Encephalitis (CASE) to benchmark clinical response in autoimmune encephalitis (AE).
No takes yet. Share an insight, caveat, or question.
Goh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: